Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -13.75x is 53% above its 2-year average of -29.23x, near the high end of its 2-year range (-73.17x–0.00x).
70.55% above its 12-month average of -46.68x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -73.17x.
INTEREST COVERAGE RATIO
-13.75x
INTEREST COVERAGE RATIO AVG TTM
-46.68x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+70.55%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-115.69%
vs the sector median at left
Liminatus Pharma, Inc. Class A Common Stock
Market Cap
$5.01M
Interest Coverage Ratio
-13.75x
TTM Avg
-46.68x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.07M
Interest Coverage Ratio
-10.70x
TTM Avg
10.43x
3Y Avg
9.52x
5Y Avg
9.52x
Market Cap
$4.95M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$4.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20M
Interest Coverage Ratio
1324.50x
TTM Avg
1324.50x
3Y Avg
1324.50x
5Y Avg
1324.50x
Market Cap
$5.21M
Interest Coverage Ratio
-25.56x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.23M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $5.01M | -13.75x | -46.68x | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.07M | -10.70x | 10.43x | 9.52x | 9.52x |
| Imunon, Inc. (IMNN)vs › | $5.06M | N/A | 1.00x | 1.02x | 1.02x |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.95M | N/A | 1.10x | 1.10x | 1.10x |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.94M | N/A | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.20M | 1324.50x | 1324.50x | 1324.50x | 1324.50x |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | -25.56x | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | -2.90x | N/A | N/A | N/A |
| Pulmatrix, Inc. (PULM)vs › | $5.28M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.63M | -16.26x | N/A | N/A | N/A |
Interest Coverage
-13.8x
Debt/Equity
4.80
Current Ratio
1.12
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -73.17x |
| 2026-03-31 | -59.07x |
| 2025-12-31 | -46.41x |
| 2025-09-30 | -36.80x |
| 2025-06-30 | -17.95x |
| 2025-03-31 | 0.00x |
| 2024-12-31 | -3.82x |
| 2024-09-30 | -11.00x |
| 2024-06-30 | -8.31x |
| 2024-03-31 | -27.14x |
| 2023-12-31 | -37.81x |
